The effect of bosentan, iloprost, epoprostenol and treprostinil on human monocyte migration Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases Year: 2009
Bosentan, epoprostenol and iloprost affect migration of human monocytes in vitro Source: Annual Congress 2008 - Regulatory mechanisms of cell activation, renewal and recruitment Year: 2008
The new clinical trials on pharmacological treatment in pulmonary arterial hypertension Source: Eur Respir J 2002; 20: 1037-1049 Year: 2002
Intravenous iloprost for treatment failure of aerosolised iloprost in pulmonary arterial hypertension Source: Eur Respir J 2002; 20: 339-343 Year: 2002
Transition from nebulised iloprost therapy to subcutaneous treprostinil Source: Eur Respir J 2004; 24: Suppl. 48, 2s Year: 2004
Inhaled iloprost plus oral sildenafil in patients with pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 324s Year: 2001
Pharmacokinetic differences between inhaled treprostinil and inhaled iloprost in severe pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 109s Year: 2004
Sildenafil and aerolized iloprost treatment in two cases with primary pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 520s Year: 2005
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2 Source: Eur Respir J 2004; 24: 353-359 Year: 2004
Successful transition from oral prostacyclin analogue (beraprost) to the selective endothelin receptor antagonist (sitaxsentan) therapy in pulmonary arterial hypertension Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment Year: 2007
Sildenafil enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 24s Year: 2002
Combination therapy in severe pulmonary hypertension with bosentan and treprostinil: successful switch from subcutaneous to intravenous application Source: Eur Respir J 2006; 28: Suppl. 50, 384s Year: 2006
Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J 2006 Oct 01;28(4):691-694 Year: 2006
Zardaverine and aerosolised iloprost in a model of acute respiratoryfailure Source: Eur Respir J 2003; 22: 342-347 Year: 2003
Inhaled iloprost plus oral sildenafil as rescue-treatment in life threatening decompensation of primary pulmonary hypertension (PPHT) Source: Eur Respir J 2003; 22: Suppl. 45, 429s Year: 2003
Consistency of the acute hemodynamic response to inhaled iloprost in pulmonary hypertension patients treated long-term with iloprost aerosol Source: Eur Respir J 2001; 18: Suppl. 33, 323s Year: 2001
Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2004; 24: 1007-1010 Year: 2004
Long-term outcome with intravenous iloprost in pulmonary arterial hypertension Source: Eur Respir J 2009; 34: 132-137 Year: 2009
Characterisation of cough evoked by inhaled treprostinil and treprostinil palmitil Source: ERJ Open Res, 7 (1) 00592-2020; 10.1183/23120541.00592-2020 Year: 2021
Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension Source: Eur Respir J 2007; 29: 469-475 Year: 2007